-
Signature
-
Jeremy Hayden
-
Issuer symbol
-
SGHT
-
Transactions as of
-
12 Nov 2025
-
Net transactions value
-
-$19,058
-
Form type
-
4
-
Filing time
-
14 Nov 2025, 19:48:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| HAYDEN JEREMY B. |
Chief Legal Officer |
C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK |
Jeremy Hayden |
14 Nov 2025 |
0001650737 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SGHT |
Common Stock |
Options Exercise |
$4,782 |
+2,440 |
+0.95% |
$1.96 |
259,030 |
12 Nov 2025 |
Direct |
F1, F2 |
| transaction |
SGHT |
Common Stock |
Options Exercise |
$1,392 |
+710 |
+0.27% |
$1.96 |
259,740 |
12 Nov 2025 |
Direct |
F1, F2 |
| transaction |
SGHT |
Common Stock |
Sale |
$25,232 |
-3,150 |
-1.2% |
$8.01 |
256,590 |
12 Nov 2025 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SGHT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,440 |
-100% |
$0.000000 |
0 |
12 Nov 2025 |
Common Stock |
2,440 |
$1.96 |
Direct |
F1, F4 |
| transaction |
SGHT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-710 |
-100% |
$0.000000 |
0 |
12 Nov 2025 |
Common Stock |
710 |
$1.96 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: